Shopping Cart 0
Cart Subtotal
USD 0

Germany Insulin Delivery Market Outlook to 2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Germany Insulin Delivery Market Outlook to 2022

Summary

GlobalData's new report, "Germany Insulin Delivery Market Outlook to 2022", provides key market data on the Germany Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Insulin Delivery market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the Germany Insulin Delivery market.

Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Insulin Delivery Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Insulin Delivery Market, Germany 8

3.1 Insulin Delivery Market, Germany, Revenue ($m), 2008-2015 8

3.2 Insulin Delivery Market, Germany, Revenue ($m), 2015-2022 10

3.2.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2008-2015 12

3.2.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2008-2015 14

3.2.3 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2015-2022 16

3.2.4 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2015-2022 18

3.3 Insulin Delivery Market, Germany, Volume (Units), 2008-2015 20

3.4 Insulin Delivery Market, Germany, Volume (Units), 2015-2022 22

3.4.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2008-2015 24

3.4.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2008-2015 26

3.4.3 Insulin Pens Market, Germany, Volume (Units), by Segment, 2015-2022 28

3.4.4 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2015-2022 30

3.5 Insulin Delivery Market, Germany, Average Price ($), 2008-2022 32

3.6 Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), 2014-2015 34

3.7 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2015 35

4 Overview of Key Companies in Germany, Insulin Delivery Market 37

4.1 Sanofi 37

4.1.1 Company Overview 37

4.2 Medtronic plc 37

4.2.1 Company Overview 37

4.3 Eli Lilly and Company 37

4.3.1 Company Overview 37

4.4 Novo Nordisk A/S 38

4.4.1 Company Overview 38

4.5 F. Hoffmann-La Roche Ltd 38

4.5.1 Company Overview 38

4.6 Becton Dickinson and Co 38

4.6.1 Company Overview 38

4.7 Ypsomed Holding AG 39

4.7.1 Company Overview 39

4.8 B. Braun Melsungen AG 39

4.8.1 Company Overview 39

5 Insulin Delivery Market Pipeline Products 40

6 Financial Deals Landscape 41

6.1 Debt Offerings 41

6.1.1 Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 41

6.2 Partnerships 42

6.2.1 Metabolon Enters into Licensing Agreement with Synlab 42

7 Recent Developments 43

7.1 Other Significant Developments 43

7.1.1 Jul 27, 2016: Bayer raises sales and earnings 43

7.2 Strategy And Business Planning 46

7.2.1 Sep 20, 2016: Bayer sets ambitious growth and earnings aspirations 46

8 Appendix 49

8.1 Research Methodology 50

8.1.1 Coverage 50

8.1.2 Secondary Research 50

8.1.3 Primary Research 51

8.1.4 Company Share Analysis 51

8.1.5 Distribution Share Analysis 51

8.1.6 Benchmarking 52

8.2 GlobalData Consulting 52

8.3 Contact Us 52

8.4 Disclaimer 53


List Of Figure

1.2 List of Figures

Figure 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 8

Figure 2: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 10

Figure 3: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 12

Figure 4: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 14

Figure 5: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 16

Figure 6: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 18

Figure 7: Insulin Delivery Market, Germany, Volume (Units), Historic, 2008-2015 20

Figure 8: Insulin Delivery Market, Germany, Volume (Units), Forecast, 2015-2022 22

Figure 9: Insulin Pens Market, Germany, Volume (Units), Historic, 2008-2015 24

Figure 10: Insulin Pumps Market, Germany, Volume (Units), Historic, 2008-2015 26

Figure 11: Insulin Pens Market, Germany, Volume (Units), Forecast, 2015-2022 28

Figure 12: Insulin Pumps Market, Germany, Volume (Units), Forecast, 2015-2022 30

Figure 13: Insulin Delivery Market, Germany, Company Share (%) 2015 35


List Of Table

1.1 List of Tables

Table 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 9

Table 2: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 11

Table 3: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 13

Table 4: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 15

Table 5: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 17

Table 6: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 19

Table 7: Insulin Delivery Market, Germany, Volume (Units), Historic, 2008-2015 21

Table 8: Insulin Delivery Market, Germany, Volume (Units), Forecast, 2015-2022 23

Table 9: Insulin Pens Market, Germany, Volume (Units), Historic, 2008-2015 25

Table 10: Insulin Pumps Market, Germany, Volume (Units), Historic, 2008-2015 27

Table 11: Insulin Pens Market, Germany, Volume (Units), Forecast, 2015-2022 29

Table 12: Insulin Pumps Market, Germany, Volume (Units), Forecast, 2015-2022 31

Table 13: Insulin Delivery Market, Germany, Average Price ($) Historic, 2008-2022 32

Table 14: Insulin Delivery Market, Germany, Average Price ($), Forecast, 2015-2022 33

Table 15: Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2014-2015 34

Table 16: Insulin Delivery Market, Germany, Company Share by Revenue ($m), USD Constant, 2015 36

Table 17: Insulin Delivery Market Pipeline Products 40

Table 18: Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 41

Table 19: Metabolon Enters into Licensing Agreement with Synlab 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp


Companies

Sanofi, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, Ypsomed Holding AG, B. Braun Melsungen AG

Germany Insulin Delivery Market Outlook to 2022

Summary

GlobalData's new report, "Germany Insulin Delivery Market Outlook to 2022", provides key market data on the Germany Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Insulin Delivery market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the Germany Insulin Delivery market.

Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Insulin Delivery Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Insulin Delivery Market, Germany 8

3.1 Insulin Delivery Market, Germany, Revenue ($m), 2008-2015 8

3.2 Insulin Delivery Market, Germany, Revenue ($m), 2015-2022 10

3.2.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2008-2015 12

3.2.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2008-2015 14

3.2.3 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2015-2022 16

3.2.4 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2015-2022 18

3.3 Insulin Delivery Market, Germany, Volume (Units), 2008-2015 20

3.4 Insulin Delivery Market, Germany, Volume (Units), 2015-2022 22

3.4.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2008-2015 24

3.4.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2008-2015 26

3.4.3 Insulin Pens Market, Germany, Volume (Units), by Segment, 2015-2022 28

3.4.4 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2015-2022 30

3.5 Insulin Delivery Market, Germany, Average Price ($), 2008-2022 32

3.6 Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), 2014-2015 34

3.7 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2015 35

4 Overview of Key Companies in Germany, Insulin Delivery Market 37

4.1 Sanofi 37

4.1.1 Company Overview 37

4.2 Medtronic plc 37

4.2.1 Company Overview 37

4.3 Eli Lilly and Company 37

4.3.1 Company Overview 37

4.4 Novo Nordisk A/S 38

4.4.1 Company Overview 38

4.5 F. Hoffmann-La Roche Ltd 38

4.5.1 Company Overview 38

4.6 Becton Dickinson and Co 38

4.6.1 Company Overview 38

4.7 Ypsomed Holding AG 39

4.7.1 Company Overview 39

4.8 B. Braun Melsungen AG 39

4.8.1 Company Overview 39

5 Insulin Delivery Market Pipeline Products 40

6 Financial Deals Landscape 41

6.1 Debt Offerings 41

6.1.1 Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 41

6.2 Partnerships 42

6.2.1 Metabolon Enters into Licensing Agreement with Synlab 42

7 Recent Developments 43

7.1 Other Significant Developments 43

7.1.1 Jul 27, 2016: Bayer raises sales and earnings 43

7.2 Strategy And Business Planning 46

7.2.1 Sep 20, 2016: Bayer sets ambitious growth and earnings aspirations 46

8 Appendix 49

8.1 Research Methodology 50

8.1.1 Coverage 50

8.1.2 Secondary Research 50

8.1.3 Primary Research 51

8.1.4 Company Share Analysis 51

8.1.5 Distribution Share Analysis 51

8.1.6 Benchmarking 52

8.2 GlobalData Consulting 52

8.3 Contact Us 52

8.4 Disclaimer 53


List Of Figure

1.2 List of Figures

Figure 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 8

Figure 2: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 10

Figure 3: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 12

Figure 4: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 14

Figure 5: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 16

Figure 6: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 18

Figure 7: Insulin Delivery Market, Germany, Volume (Units), Historic, 2008-2015 20

Figure 8: Insulin Delivery Market, Germany, Volume (Units), Forecast, 2015-2022 22

Figure 9: Insulin Pens Market, Germany, Volume (Units), Historic, 2008-2015 24

Figure 10: Insulin Pumps Market, Germany, Volume (Units), Historic, 2008-2015 26

Figure 11: Insulin Pens Market, Germany, Volume (Units), Forecast, 2015-2022 28

Figure 12: Insulin Pumps Market, Germany, Volume (Units), Forecast, 2015-2022 30

Figure 13: Insulin Delivery Market, Germany, Company Share (%) 2015 35


List Of Table

1.1 List of Tables

Table 1: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 9

Table 2: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 11

Table 3: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 13

Table 4: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2008-2015 15

Table 5: Insulin Pens Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 17

Table 6: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2015-2022 19

Table 7: Insulin Delivery Market, Germany, Volume (Units), Historic, 2008-2015 21

Table 8: Insulin Delivery Market, Germany, Volume (Units), Forecast, 2015-2022 23

Table 9: Insulin Pens Market, Germany, Volume (Units), Historic, 2008-2015 25

Table 10: Insulin Pumps Market, Germany, Volume (Units), Historic, 2008-2015 27

Table 11: Insulin Pens Market, Germany, Volume (Units), Forecast, 2015-2022 29

Table 12: Insulin Pumps Market, Germany, Volume (Units), Forecast, 2015-2022 31

Table 13: Insulin Delivery Market, Germany, Average Price ($) Historic, 2008-2022 32

Table 14: Insulin Delivery Market, Germany, Average Price ($), Forecast, 2015-2022 33

Table 15: Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2014-2015 34

Table 16: Insulin Delivery Market, Germany, Company Share by Revenue ($m), USD Constant, 2015 36

Table 17: Insulin Delivery Market Pipeline Products 40

Table 18: Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 41

Table 19: Metabolon Enters into Licensing Agreement with Synlab 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp


Companies

Sanofi, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, Ypsomed Holding AG, B. Braun Melsungen AG